Breaking News

GVK Bio Licenses Biomarker Database to FDA

GVK Biosciences has extended its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the FDA.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GVK Biosciences has extended its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the FDA. The GOBIOM database is a comprehensive collection of clinically evaluated, exploratory and preclinical biomarkers associated with different therapeutic areas reported in global clinical trials. It contains information on 12,000 biomarkers comprising biochemical, genomic, imaging, metabolite, cellular and physiological markers. Sreeni Devidas, vice president, sales and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters